Oncology Medical News about Ewing sarcoma

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
New Certification for Hermatology-Oncology Coding

Dorothy J. Schirf, MD

Technology Advances

Groundbreaking Nanolaser Grants Access to DNA

Sara Hartley

Cancer Science

Low Sugar Environment Promotes Oncogenic Mutations

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1
Medical Oncology, 11/04/09

Singh M et al. – Curcumin is a naturally occurring polyphenolic compound found in the turmeric, which is used as food additive in Indian cooking and as a therapeutic agent in traditional Indian medicine. Curcumin is currently under investigation as a chemotherapeutic and chemopreventive agent in adult cancer models at both pre–clinical and clinical levels. The findings indicate a need for further evaluation of curcumin in chemotherapy and chemoprevention of Ewing sarcoma.

<< Previous
MDR1 polymorphism role in patients treated with cetuximab and...

Next >>
Good things come in small packages: low-dose radiation as...